Courtesy of Singapore Stem Cell Bank From J.Crook.Oct-4 labelled hESC. Counterstained with DAPI. Courtesy of Singapore Stem Cell Bank From Robert Zweigerdt.Confocal imaging of selected hESC derived cardiomyocytes subjected to immunocytochemical staining for α-MHC, α-actinin, and MLC2v revealed characteristic sarcomeric cross-striations. Counterstained with DAPI. Courtesy of Institute of Medical Biology (IMB). Building of Immunos. 2009 Feng et al : Publication on "Reprogramming of fibroblasts into induced pluripotent stem cells with orphan nuclear receptor Esrrb"
Grants
SSCC Grant Call 2010

Introduction

The Singapore Stem Cell Consortium (SSCC) is an initiative of the A*STAR Biomedical Research Council (BMRC) with the aim of establishing a coordinated and focused translational research and development programme in stem cells.

It seeks to catalyze the translation of basic stem cell research into clinically viable stem cell therapies for chronic, debilitating diseases, by building strong linkages between basic science and clinical research groups.

It aspires to develop enabling platform technologies for eventual therapeutic use of stem cell research.

In addition, the SSCC also has an interest in using stem cells to create models of mammalian development and disease states, as well as providing cellular assays for the identification of novel signaling molecules, pathways, and the development of new drugs.

The SSCC is now inviting research proposals for experimental work which caters to 3 distinct categories :

 Directed Differentiation

 Early Career Principle Investigators

 Pivotal Pre-Clinical Studies

Applications

 Directed Differentiation

 Early Career Principle Investigators

 Pivotal Pre-Clinical Studies

 Grant Application Form

 Grant Application Form – Appendix A